home > research channels > sectors > pharma > reports

 
Reports Archive
Date Heading Pages Author Download
Jan-12 Indian Pharma 3Q Preview 15 Citi
Jan-12 Pharma – Q3FY12 Preview 4 Khandwala Securities
Jan-12 India Pharmaceuticals 49 HSBC
Jan-12 Marching ahead in turbulent times 10 Edelweiss Securities
Jan-12 Good bet for turbulent times 5 Reliance Securities
Dec-11 Remedy for growth 35 Edelweiss Securities
Dec-11 Key Takeaways from Indian Pharma Conference, Dec 8-9 21 Citi
Nov-11 Pharma Confluence 42 Emkay Research
Nov-11 AIOCD releases impact estimates for NPPP 2011 4 Nomura
Nov-11 The party begins 9 Edelweiss Securities
Nov-11 US IMS review for September 11 and expected catalysts 19 Nomura
Nov-11 NPPP-2011, not as pessimist as perceived earlier 5 PINC Research
Oct-11 New report: Stay the course 4 Credit Suisse
Oct-11 Health Check: Testing Sensitivity to Key Macro Factors 92 Citi
Oct-11 US IMS review for August 11 and expected catalysts 18 Nomura Securities
Oct-11 2QFY12 Preview - expect moderate growth 22 Nomura Securities
Oct-11 FDI Cap retained at 100%, Pharma deals to come under increased scrutiny 3 Reliance Securities
Oct-11 2QFY12 preview: Domestic slowdown to hit growth 5 Anand Rathi
Oct-11 On thin edge of wedge 16 Edelweiss Securities
Oct-11 Pharma Monthly Update 8 PINC Research
Sep-11 Challenges Ahead 85 Emkay Research
Sep-11 Domestic Pharma Monthly Review 32 Edelweiss Securities
Sep-11 Indian Pharma & Ag Daily Dose 8 Citi
Sep-11 Financial Performance with Outlook and Valuation 65 JM Financial
Sep-11 Indian Respiratory Market 25 BRICS
Sep-11 Pharma Monthly Update 7 PINC Research
Aug-11 Domestic Formulations 150 Motilal Oswal
Aug-11 Speed breakers show up 5 India Infoline
Aug-11 India Pharma : 1QFY12 - Lower margins impacted profitability 6 Anand Rathi
Aug-11 2QCY11 Indian DMF filings 6 JM Financial
Aug-11 Indian Pharma & Ag Daily Dose 8 Citi
Jul-11 1QFY12 Pharma Sector Preview 4 Nirmal Bang
Jul-11 Indian Pharma & Ag Daily Dose 8 Citi
Jul-11 Pricing to perfection 6 Edelweiss Securities
Jul-11 1QFY12 Preview - Steady Revenue, Lower Profit 5 Anand Rathi
Jul-11 Pricing To Perfection 6 Edelweiss Research
Jun-11 Domestic Pharma Review 20 Edelweiss
Jun-11 Teva loses SJ motion for Copaxone, but gets reprieve in Seasonique 4 JM Financial
Jun-11 Edel Pulse: Pharmaceuticals 142 Edelweiss Research
Jun-11 Indian Pharma & Ag Daily Dose 8 Citi
Apr-11 Indian Pharma & Ag Daily Dose 8 Citi
Apr-11 Indian Pharma & Ag Daily Dose 8 Citi
Apr-11 Q4FY2011 Result Preview 6 PINC Research
Mar-11 Global generics round-up 24 JM Financial
Mar-11 Domestic formulations: Monthly review 38 Nomura Securities
Mar-11 Indian Pharma & Ag Daily Dose 8 Citi
Mar-11 Pharma Pill - Monthly Update 11 ICICI Securities
Mar-11 Indian Pharma & Ag Daily Dose 8 Citi
Mar-11 ANDA approvals in February 2011 3 Sharekhan
Mar-11 Domestic formulations: Monthly review 38 Nomura
Mar-11 Healthy balance sheet supports strong inorganic growth 4 Credit Suisse
Feb-11 Pharma Update - 4QCY10 Indian DMF filings 6 JM Financial
Jan-11 3QFY11 preview - Sustained momentum 5 Anand Rathi
Jan-11 Pharmaceuticals Q3FY11 Results Preview 8 Emkay Global Financial Services Ltd.
Nov-10 Pharma Q2FY11 Results Review 8 Emkay
Jul-10 Aiming High In The US Generics Market 64 IIFL
Jul-10 The Great Indian Sale Is On! 23 IDFC
Apr-10 R&D - Opportunities And Valuation Methodology 12 Angel Securities
Feb-10 Pharmaceutical Q3Fy10 Review 5 Emkay Research
Jan-10 Q3FY2010 Pharma earnings preview 3 Sharekhan
Nov-09 Pharma Sector - Alliances / Acquisitions At Work 31 Emkay
Sep-09 Firing On All Cylinders 49 Emkay
Jul-09 US FDA Warning Letters 3 Emkay
May-09 MNC Pharma Sector - Global Local 38 Emkay Research
Feb-09 Pharmaceuticals Sector Update 24 Motilal Oswal
Jan-09 World Pharma Market Update: US market - sharp fall 6 Prabhudas Lilladher
Jan-09 Q3FY2009 Pharma Earnings Preview 4 Sharekhan
Dec-08 World Pharma Market Update 5 Prabhudas Lilladher
Oct-08 World Pharma Market Update - Japanese market – on the growth path 5 Prabhudas Lilladher
Oct-08 Pharma Fact Sheet - September 2008 4 Edelweiss Securities
Sep-08 Pharmaceuticals - Cherry Picks 92 Motilal Oswal
Sep-08 Pharma Fact Sheet - August 2008 4 Edelweiss Securities
Aug-08 US Market - The Slowdown Continues 4 Prabhudas Lilladher
Jun-08 Pharma Fact Sheet 4 Edelweiss
Jun-08 Pharma Sector Update 4 Edelweiss
Apr-08 Indian Pharmaceutical & Biotechnology Industry 9 Virtus Global Partners
Mar-08 World Pharma Market 4 Prabhudas Lilladher
Mar-08 Pharmaceuticals - Time To Re-look 39 Edelweiss
Feb-08 Sector Update - Q3FY08 Result Review 8 Religre Securities
Jan-08 Sectoral Report Pharma 8 PINC
Dec-07 World Pharma Market Update 3 Prabhudas Lilladher
Nov-07 Pharma Pulse 42 ENAM
Oct-07 World Pharma Market Update 3 Prabhudas Lilladher
Sep-07 Pharma Fact Sheet 3 Edelweiss
Aug-07 World Pharma Market Update 3 Prabhudas Lilladher
Jul-07 World Pharma Market Update 3 Prabhudas Lilladher
Jul-07 July 2007 Earnings Preview 19 Karvy
May-07 Domestic Formulations 76 Edelweiss
Apr-07 World Pharma Market Update 3 Prabhudas Lilladher
Mar-07 World Pharma market 3 Prabhudas Lilladher
Jan-07 Pharma Sector - Dec 2006 Earnings Preview 17 Karvy
Jan-07 Nicholas Piramal - Eli Lilly JV Presentation 8 Nicholas Piramal - Eli Lilly JV
Jan-07 Nicholas Piramal R&D Presentation 36 Nicholas Piramal
Nov-06 Quarterly Update : Pharma 18 ETIG
Oct-06 Pharma Sector Results Preview 4 Edelweiss
Oct-06 Earnings Preview 14 Karvy
Sep-06 Shwarz Pharma 22 Shwarz Pharma
Sep-06 Top Ten R&d Spenders In The Indian Pharma Industry 3 ETIG
Aug-06 Barr Pharma Invetor Presentation 17 Barr Pharma
Aug-06 Annual Report - 2006 52 Mylan Pharma
Aug-06 TEVA Presentation 37 TEVA Pharma
Aug-06 Epidemics 28 Edelweiss
Aug-06 Quarterly Update: Pharma 10 ETIG
Jul-06 Pharma Sector - June 2006 Earnings Preview 12 Karvy
Jun-06 ETIG Pharma Sector Update 4 ETIG
May-06 Sky is the limit 75 India Infoline
Apr-06 Pharma Results Preview 11 Karvy
Mar-06 Actavis Presentation 33 Actavis
Mar-06 Bird Flu Timeline 10 WHO
Mar-06 Pharma Harma Fact Act Sheet 4 Edelweiss
Feb-06 Operations Management in Hospital Administration 13 Dr Jamshed Modi,SP Jain Institute of Management and Research
Feb-06 ETIG Pharma Sector Note 17 ETIG
Feb-06 Quarterly Update: Pharma 4 ETIG
Feb-06 Pharma Sector Review 2 Edelweiss
Dec-05 World Pharma Market 3 HDFC Sec
Aug-05 ICRA Sector Analysis on Biotechnology - August 2005 30 ICRA
Aug-05 Health Insurance Note - August 2005 4 PHDCCI
2005 Par Pharma Annual Report 111 Par Pharma
2005 Watson Pharma - 10K Declaration 85 Watson Pharma
2005 India Prescription for growth 11 PriceWaterHouse Coopers
2004/2005 CorpFin Insights - Global Pharma M&A 16 PriceWaterHouse Coopers
Jun-04 ICRA Sectir Analysis on Drugs & Pharmaceuticals - June 2004 11 ICRA
1999 HEALTH CAST 2010SM 52 PriceWaterHouse Coopers